سعر سولفكس 250مجم/5مل شراب 120مل 2022

Solvex 250 mg/5 ml syrup, 120 ml bottle (Sedico, Egypt): carbocisteine oral syrup, a mucolytic for respiratory disorders with excessive or viscous mucus.

• Adjunctive therapy of respiratory tract disorders characterised by excessive or viscous mucus.Population: Adults and childrenHealth Products Regulatory Authority (HPRA), Ireland

• Frequency not known: nausea, vomiting, gastrointestinal upset or epigastric discomfort, and gastrointestinal bleeding.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland
• Allergic skin eruptions, anaphylactic reactions and fixed drug eruption; isolated cases of bullous dermatitis such as Stevens-Johnson syndrome and erythema multiforme.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

• Known hypersensitivity to carbocisteine (or to any excipient).International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland
• Active peptic ulceration.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

• Use with caution in the elderly, in patients with a history of gastroduodenal ulcer, and with medicines known to cause gastrointestinal bleeding; stop treatment if gastrointestinal bleeding occurs.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland
• The reference syrup contains sucrose (2 g/5 ml) and is unsuitable for patients with hereditary fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase deficiency; the Egyptian excipient list was not verified.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

• Animal tests revealed no teratogenic effects, but it should not be used during pregnancy unless considered essential by the physician.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland
• Effects in lactation are not known.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

• Carbocisteine: Affects the nature and amount of mucus glycoprotein secreted by the respiratory tract: keeps secreted glycoprotein normal after irritant exposure and reduces goblet-cell hyperplasia.